LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: Controversies in the management of adjuvant breast cancer with taxanes: review of the current literature.

    Araque Arroyo, Patricia / Ubago Pérez, Ruth / Cancela Díez, Bárbara / Fernández Feijóo, Maria Amalia / Hernández Magdalena, Jorge / Calleja Hernández, Miguel Angel

    Cancer treatment reviews

    2011  Band 37, Heft 2, Seite(n) 105–110

    Abstract: Taxanes offer clear benefits in adjuvant chemotherapy for early breast cancer. This review examines evidence to date on the clinical effectiveness and cost-effectiveness of their use in the adjuvant treatment of women with early breast cancer, based on ... ...

    Abstract Taxanes offer clear benefits in adjuvant chemotherapy for early breast cancer. This review examines evidence to date on the clinical effectiveness and cost-effectiveness of their use in the adjuvant treatment of women with early breast cancer, based on three meta-analyses, one systematic review, five clinical practice guidelines and 16 randomized clinical trials. Against the background of a major increase in the use of docetaxel rather than paclitaxel in our setting over the past few years, implying a major increase in costs, we examined whether this higher use of docetaxel is supported by the available evidence. In this wide study, we found no evidence that regimens containing docetaxel yield greater benefits than those including paclitaxel. From an effectiveness standpoint, the change from paclitaxel to docetaxel in our setting is not justified.
    Mesh-Begriff(e) Breast Neoplasms/drug therapy ; Breast Neoplasms/mortality ; Chemotherapy, Adjuvant ; Cost-Benefit Analysis ; Disease-Free Survival ; Female ; Humans ; Paclitaxel/therapeutic use ; Practice Guidelines as Topic ; Taxoids/therapeutic use
    Chemische Substanzen Taxoids ; docetaxel (15H5577CQD) ; Paclitaxel (P88XT4IS4D)
    Sprache Englisch
    Erscheinungsdatum 2011-04
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Meta-Analysis ; Review
    ZDB-ID 125102-8
    ISSN 1532-1967 ; 0305-7372
    ISSN (online) 1532-1967
    ISSN 0305-7372
    DOI 10.1016/j.ctrv.2010.06.002
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 1022: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 611: Hefte anzeigen

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation.

    Arroyo, Patricia Araque / Perez, Ruth Ubago / Feijoo, Maria Amalia Fernandez / Hernandez, Miguel Angel Calleja

    Journal of cancer research and therapeutics

    2010  Band 6, Heft 4, Seite(n) 573–574

    Abstract: A 75-year-old man diagnosed with lower esophageal adenocarcinoma suffered from epirubicin extravasation during the second cycle of neoadjuvant chemotherapy with epirubicin and oxaliplatin. A full recovery was achieved after treatment with dexrazoxane ( ... ...

    Abstract A 75-year-old man diagnosed with lower esophageal adenocarcinoma suffered from epirubicin extravasation during the second cycle of neoadjuvant chemotherapy with epirubicin and oxaliplatin. A full recovery was achieved after treatment with dexrazoxane (Cardioxane® ). This is the first time in our hospital that extravasation of an anthracycline has been treated with dexrazoxane. We used Cardioxane® , approved for the prevention of anthracycline-induced cardiotoxicity, while Savene® is indicated for the treatment of anthracycline extravasation. The treatment was effective, and the selection of Cardioxane® (seven-fold cheaper than Savene® ) yielded a cost saving. Consequently, Cardioxane® has been included in our guidelines for anthracycline extravasation.
    Mesh-Begriff(e) Aged ; Antineoplastic Agents/adverse effects ; Cost-Benefit Analysis ; Epirubicin/adverse effects ; Extravasation of Diagnostic and Therapeutic Materials ; Humans ; Male ; Razoxane/economics ; Razoxane/therapeutic use ; Treatment Outcome
    Chemische Substanzen Antineoplastic Agents ; Epirubicin (3Z8479ZZ5X) ; Razoxane (5AR83PR647)
    Sprache Englisch
    Erscheinungsdatum 2010-10
    Erscheinungsland India
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 2187633-2
    ISSN 1998-4138 ; 0973-1482
    ISSN (online) 1998-4138
    ISSN 0973-1482
    DOI 10.4103/0973-1482.77081
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang